Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

IL-2 is a natural, T cell–derived cytokine that stimulates the cytotoxic functions of T and natural killer cells. IL-2 monotherapy has been evaluated in several randomized clinical trials (RCTs) for remission maintenance in patients with acute myeloid leukemia (AML) in first complete remission (CR1)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Buyse, Marc, Squifflet, Pierre, Lange, Beverly J., Alonzo, Todd A., Larson, Richard A., Kolitz, Jonathan E., George, Stephen L., Bloomfield, Clara D., Castaigne, Sylvie, Chevret, Sylvie, Blaise, Didier, Maraninchi, Dominique, Lucchesi, Kathryn J., Burzykowski, Tomasz
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539044/
https://ncbi.nlm.nih.gov/pubmed/21518931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-337725
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados